Sigyn Therapeutics, Inc. SEC filings SIGY

Sigyn Therapeutics, Inc. has 175 filings in SEC EDGAR's recent list, going back to May 27, 2015. Its latest annual report, Form 10-K, was filed on Apr 15, 2025 for the period ended Dec 31, 2024. The latest quarterly report (Form 10-Q) was filed on Nov 14, 2025, covering the quarter ended Sep 30, 2025. The most recent current report (Form 8-K) was filed on Feb 20, 2026 (material agreement, unregistered share sale). The company's fiscal year ends on December 31.

Form Description Filed Period
8-K Current report
Material agreement, Unregistered share sale
 Feb 20, 2026 Feb 20, 2026
8-K Current report
Material agreement, Unregistered share sale, Officer or director change, Other events
 Aug 15, 2025 Aug 14, 2025
8-K Current report
Officer or director change, Regulation FD disclosure
 Mar 7, 2025 Feb 26, 2025
8-K Current report
Officer or director change
 Jan 16, 2025 Jan 11, 2025
8-K Current report
Bylaw or fiscal year change
 Jan 6, 2025 Dec 30, 2024
8-K Current report
Unregistered share sale
 Oct 16, 2024 Oct 7, 2024
8-K/A Amended current report
Unregistered share sale
 Oct 16, 2024 Oct 4, 2024
8-K Current report
Unregistered share sale
 Oct 7, 2024 Oct 4, 2024
8-K Current report
Other events
 Jun 6, 2024 Jun 6, 2024
8-K Current report
Other events
 May 15, 2024 May 15, 2024
8-K Current report
Material agreement
 Apr 16, 2024 Apr 16, 2024
8-K Current report
Other events
 Jan 31, 2024 Jan 31, 2024
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change
 Jan 30, 2024 Jan 30, 2024
8-K Current report
Material agreement, Other events
 Jan 11, 2024 Jan 9, 2024
8-K Current report
Regulation FD disclosure
 Jan 8, 2024 Jan 4, 2024
8-K Current report
Officer or director change
 Dec 12, 2023 Dec 6, 2023
8-K Current report
Other events
 Oct 26, 2023 Oct 20, 2023
8-K Current report
Regulation FD disclosure
 Oct 4, 2023 Oct 4, 2023
8-K Current report
Material agreement
 Sep 19, 2023 Sep 14, 2023
8-K Current report
Material agreement, Unregistered share sale, Change to shareholder rights, Bylaw or fiscal year change
 Jul 7, 2023 Jun 30, 2023
8-K Current report
Other events
 Jun 8, 2023 Jun 8, 2023
8-K Current report
Regulation FD disclosure
 Apr 13, 2023 Apr 11, 2023
8-K Current report
Officer or director change
 Oct 5, 2022 Oct 3, 2022
8-K Current report
Material agreement, Officer or director change
 Mar 9, 2022 Mar 9, 2022
8-K Current report
Other events
 Mar 1, 2022 Feb 23, 2022
8-K/A Amended current report
Material agreement
 Oct 26, 2021 Oct 20, 2021
8-K Current report
Material agreement, Unregistered share sale
 Oct 25, 2021 Oct 20, 2021
8-K Current report
Material agreement, Unregistered share sale
 May 14, 2021 May 10, 2021
8-K/A Amended current report Dec 30, 2020 Sep 30, 2020
8-K Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Change in control, Officer or director change, Bylaw or fiscal year change
 Oct 23, 2020 Aug 25, 2020
8-K Current report
Material agreement, Other events
 Aug 31, 2020 Aug 25, 2020
8-K Current report
Other events
 Aug 10, 2020 Aug 10, 2020
8-K Current report
Bylaw or fiscal year change
 May 12, 2020 May 12, 2020
8-K Current report
Material agreement
 Mar 16, 2020 Mar 12, 2020
8-K/A Amended current report
Auditor change, Other events
 Jan 6, 2020 Dec 12, 2019
8-K Current report
Auditor change, Other events
 Jan 3, 2020 Dec 12, 2019
8-K Current report
Bylaw or fiscal year change
 Nov 14, 2019 Nov 13, 2019
8-K Current report
Material agreement, New debt, Unregistered share sale
 Oct 3, 2019 Sep 29, 2019
8-K Current report
Material agreement, Acquisition or sale of assets
 Jan 7, 2019 Jan 4, 2019
8-K Current report
Auditor change
 Oct 17, 2018 Oct 8, 2018
8-K Current report
Material agreement, New debt, Unregistered share sale, Regulation FD disclosure
 Feb 23, 2018 Feb 20, 2018
8-K Current report
Material agreement, New debt, Unregistered share sale, Regulation FD disclosure
 Jan 8, 2018 Jan 3, 2018
8-K Current report
Material agreement, New debt, Unregistered share sale, Bylaw or fiscal year change
 Nov 16, 2017 Nov 10, 2017
8-K Current report
Regulation FD disclosure
 Sep 5, 2017 Sep 5, 2017
8-K/A Amended current report
Acquisition or sale of assets
 Aug 7, 2017 Aug 7, 2017
8-K Current report
Material agreement, Unregistered share sale
 Jul 3, 2017 Jun 30, 2017
8-K Current report
Material agreement, Other events
 May 31, 2017 May 30, 2017
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change
 May 24, 2017 May 19, 2017
8-K Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale
 Dec 2, 2016 Dec 1, 2016
8-K Current report
Material agreement, New debt, Unregistered share sale, Officer or director change
 Nov 14, 2016 Nov 10, 2016
8-K Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale
 Nov 4, 2016 Nov 3, 2016
8-K Current report
Auditor change
 Mar 14, 2016 Mar 9, 2016
8-K Current report
Material agreement, Other events
 Jan 22, 2016 Jan 21, 2016
8-K Current report
Material agreement, Unregistered share sale, Officer or director change, Bylaw or fiscal year change, Shareholder vote results, Other events
 Dec 24, 2015 Dec 22, 2015

Showing 54 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
SIGY (OTC)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Beverly Hills, CA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1642159
Former names
Reign Resources Corp (until Oct 23, 2020); Reign Sapphire Corp (until May 12, 2020)

Other Surgical & Medical Instruments & Apparatus companies

All 151 Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.